Glenn S Hamroff MD
Adult Congenital Heart Disease, Echocardiography, Nuclear Cardiology, Non-Invasive Cardiology
Non-invsassive cardiology
Join to View Full Profile
1978 Crompond RdCortlandt Manor, NY 10567
Phone+1 914-736-0703
Fax+1 914-736-9234
Dr. Hamroff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Montefiore Medical CenterCardiology, 1994 - 1997
Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Advanced Heart Failure and Transplant Cardiology, 1995 - 1996- Montefiore Medical CenterMedicine, 1993 - 1994
- Montefiore Medical CenterMedicine, 1990 - 1993
State University of New York Downstate Medical Center College of MedicineClass of 1990
Certifications & Licensure
NY State Medical License 1991 - 2027
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Phi Beta Kappa 1986
- Join now to see all
Publications & Presentations
PubMed
- 168 citationsAddition of Angiotensin II Receptor Blockade to Maximal Angiotensin-Converting Enzyme Inhibition Improves Exercise Capacity in Patients With Severe Congestive Heart Fa...G. Hamroff, Stuart D. Katz, Donna M. Mancini, I. Blaufarb, Rachel Bijou
Circulation. 1999-03-02 - 41 citationsAngiotensin II-receptor blockade further reduces afterload safely in patients maximally treated with angiotensin-converting enzyme inhibitors for heart failureGlenn Hamroff, Ira Blaufarb, Donna Mancini, Stuart D. Katz, Rachel Bijou
Journal of Cardiovascular Pharmacology. 1997-10-01
Journal Articles
- Angiotensin II Receptor Blockade Further Reduces Afterload Safely in Patients Maximally Treated with ACE Inhibitors for Heart FailureHamroff G, Blaufarb I, Mancini D, Katz S, Demopoulos L, Bijou R, Jondeau G, Olivari MT, Thomas S, Lejemtel T, Journal of Cardiovascular Pharmacology, 1/1/1997
- Clinical Benefit of Long Term Angiotensin II Receptor Blockade In Patients With Severe Symptoms of Congestive Heart Failure Despite full Angiotensin Converting Enzyme ...Hamroff G, Blaufarb I, Mancini D, Katz S, Demopoulos L, Bijou R, Jondeau G, Olivari MT, Thomas S, Lejemtel T, Circulation, 1/1/1997
- A Comparison of Sprint vs. Progressive Treadmill Exercise in the Evaluation of Cardiac Arrhythmias.Ferrick K, Hamroff G, Roth J, Kim S, Fisher J, American Heart Journal
- Join now to see all
Abstracts/Posters
- Clinical Benefit of Long Term Angiotensin II Receptor Blockade In Patients With Severe Symptoms of Congestive Heart Failure Despite full Angiotensin Converting Enzyme ...Hamroff G, Blaufarb I, Mancini D, Katz S, Demopoulos L, Bijou R, Jondeau G, Olivari MT, Thomas S, Lejemtel T, 1998 scientific sessions of the American College of Cardiology
- Clinical Benefit of Long Term Angiotensin II Receptor Blockade In Patients With Severe Symptoms of Congestive Heart Failure Despite full Angiotensin Converting Enzyme ...Hamroff G, Blaufarb I, Mancini D, Katz S, Demopoulos L, Bijou R, Jondeau G, Olivari MT, Thomas S, Lejemtel T, Circulation 1997
Lectures
- Clinical Benefit of Long Term Angiotensin II Receptor Blockade In Patients With Severe Symptoms of Congestive Heart Failure Despite full Angiotensin Converting Enzyme ...American College of Cardiology - 1/1/1998
- Angiotensin II Receptor Blockade Further Reduces Afterload Safely in Patients Maximally Treated with ACE Inhibitors for Heart FailureAmerican Heart Association Scientific Secessions - 1/1/1996
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
